First Time Loading...

Olema Pharmaceuticals Inc
NASDAQ:OLMA

Watchlist Manager
Olema Pharmaceuticals Inc Logo
Olema Pharmaceuticals Inc
NASDAQ:OLMA
Watchlist
Price: 10.5921 USD -0.73%
Updated: May 6, 2024

Olema Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Olema Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Olema Pharmaceuticals Inc
NASDAQ:OLMA
Cash from Financing Activities
$133.4m
CAGR 3-Years
-28%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Olema Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
133.4m USD

Based on the financial report for Dec 31, 2023, Olema Pharmaceuticals Inc's Cash from Financing Activities amounts to 133.4m USD.

What is Olema Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
91%

Over the last year, the Cash from Financing Activities growth was 27 695%. The average annual Cash from Financing Activities growth rates for Olema Pharmaceuticals Inc have been -28% over the past three years , 91% over the past five years .